LEADER 01297nam  2200397   450 
001 9910568277903321
005 20221211154713.0
010   $a981-16-8444-8
035   $a(MiAaPQ)EBC6977316
035   $a(Au-PeEL)EBL6977316
035   $a(CKB)22046318300041
035   $a(EXLCZ)9922046318300041
100   $a20221211d2022      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aProbiotic research in therapeutics$hVolume 5 $emetabolic diseases and gut bacteria /$fIndu Pal Kaur [and three others], editors
210  1$aSingapore :$cSpringer,$d[2022]
210  4$dİ2022
215   $a1 online resource (281 pages)
311 08$aPrint version: Kaur, Indu Pal Probiotic Research in Therapeutics Singapore : Springer,c2022 9789811684432 
606   $aGastrointestinal system$xMicrobiology
606   $aNervous system$xDegeneration
615  0$aGastrointestinal system$xMicrobiology.
615  0$aNervous system$xDegeneration.
676   $a612.32
702   $aKaur$b Indu Pal
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910568277903321
996   $aProbiotic research in therapeutics$92596964
997   $aUNINA